 |
SUZHOU, China, July 28, 2025 /PRNewswire/ -- ImmVira Group ("ImmVira" or the "Company")recently announced that its engineered exosome products MVR-EX104 ("EX104", for alopecia treatment) and MVR-EX105 ("EX105", for localized fat accumulation) have obtained International Nomenclature of Cosmetic Ingredients (INCI) designations following review by the International Cosmetic Ingredient Nomenclature Committee (INC). This dual milestone underscores ImmVira's breakthrough leadership in functional aesthetic ingredients, bring forward revolutionary consumer healthcare solutions.
Leveraging proprietary OVPENS technology platform, ImmVira developed its engineered exosome portfolio—including MVR-EX103 for skin-related conditions (INCI name granted in April 2025), EX104 for alopecia treatment, and EX105 for localized fat accumulation—for direct commercialization with flexible registration pathways, targeting substantial aging-related market opportunities. Concurrently, on the clinical therapeutic front, our exosome candidates also deliver a novel treatment option for those chronic, hard-to-treat disease indications, such as wound healing and pulmonary fibrosis.
As the universal "passport" for aesthetic ingredients, INCI standards cover multiple major markets including the US, EU, and Japan. This certification validates ImmVira's pioneering position in engineered exosome technology, enables direct overseas market entry, and enhances consumer trust through INCI's mandated ingredient transparency.
Per Frost and Sullivan, global alopecia treatment and localized adipose accumulation management treatment markets will reach $89.9 billion and $191.5 billion respectively by 2033. Utilizing engineered exosome that co-delivers multi-functional proteins with designed precise efficacy and enhanced skin penetration, EX104 and EX105 enable deep cellular-level modulation through non-invasive topical use, reshaping traditional treatment paradigms.
"From skin repair (EX103) to hair regeneration (EX104) and localized fat reduction (EX105), our OVPENS platform demonstrates sustainable capacity for breakthrough healthcare innovations. " stated Dr. Zhou Guoying, CEO of ImmVira. "Leveraging precision-engineered design and targeted delivery of multiplex functional proteins, we maintain a strategically balanced portfolio that directly targets high-value, aging-related market opportunities with strong business acumen. The platform's inherent expandability allows us to rapidly develop new pipeline candidates to address specific indication needs, enabling novel treatment modalities that empower the public to achieve health and beauty."
With this dual certification, ImmVira solidifies its role as the global industrial leader in engineered exosomes. ImmVira is accelerating development of a worldwide health and wellness product matrix spanning skin health, hair management and fat reduction, ushering in a new chapter for home-use professional-grade bioactive solutions.
About ImmVira
ImmVira is a global leading clinical-stage biotechnology company that is powered by proprietary biological engineering technology, and is dedicated to the discovery, development, manufacture and commercialization of novel oncolytic immunotherapies and engineered exosome therapies. We have strategically designed and built a risk-balanced product portfolio that comprised both potentially best-in-class oncolytic immunotherapy candidates for solid tumors and innovative engineered exosome assets for clinical application or direct commercialization. Driven by our strategic priority to become a global leader in the full spectrum of bladder cancer treatment development, we have adopted a rationalized, adaptive approach to advance oncolytic immunotherapy candidates with high clinical potential globally. In parallel, leveraging our deep expertise in biological engineering, we have pioneered development of engineered exosome candidates targeting chronic, hard-to-treat diseases as well as age-related conditions. These selected engineered exosome assets are being deliberately accelerated through strategic, differentiated regulatory pathways to enable expedited commercialization and generate sustainable cash flows that will fuel our broader drug development efforts.
SUZHOU, China, July 28, 2025 /PRNewswire/ -- ImmVira Group ("ImmVira" or the "Company")recently announced that its engineered exosome products MVR-EX104 ("EX104", for alopecia treatment) and MVR-EX105 ("EX105", for localized fat accumulation) have obtained International Nomenclature of Cosmetic Ingredients (INCI) designations following review by the International Cosmetic Ingredient Nomenclature Committee (INC). This dual milestone underscores ImmVira's breakthrough leadership in functional aesthetic ingredients, bring forward revolutionary consumer healthcare solutions.
Leveraging proprietary OVPENS technology platform, ImmVira developed its engineered exosome portfolio—including MVR-EX103 for skin-related conditions (INCI name granted in April 2025), EX104 for alopecia treatment, and EX105 for localized fat accumulation—for direct commercialization with flexible registration pathways, targeting substantial aging-related market opportunities. Concurrently, on the clinical therapeutic front, our exosome candidates also deliver a novel treatment option for those chronic, hard-to-treat disease indications, such as wound healing and pulmonary fibrosis.
As the universal "passport" for aesthetic ingredients, INCI standards cover multiple major markets including the US, EU, and Japan. This certification validates ImmVira's pioneering position in engineered exosome technology, enables direct overseas market entry, and enhances consumer trust through INCI's mandated ingredient transparency.
Per Frost and Sullivan, global alopecia treatment and localized adipose accumulation management treatment markets will reach $89.9 billion and $191.5 billion respectively by 2033. Utilizing engineered exosome that co-delivers multi-functional proteins with designed precise efficacy and enhanced skin penetration, EX104 and EX105 enable deep cellular-level modulation through non-invasive topical use, reshaping traditional treatment paradigms.
"From skin repair (EX103) to hair regeneration (EX104) and localized fat reduction (EX105), our OVPENS platform demonstrates sustainable capacity for breakthrough healthcare innovations. " stated Dr. Zhou Guoying, CEO of ImmVira. "Leveraging precision-engineered design and targeted delivery of multiplex functional proteins, we maintain a strategically balanced portfolio that directly targets high-value, aging-related market opportunities with strong business acumen. The platform's inherent expandability allows us to rapidly develop new pipeline candidates to address specific indication needs, enabling novel treatment modalities that empower the public to achieve health and beauty."
With this dual certification, ImmVira solidifies its role as the global industrial leader in engineered exosomes. ImmVira is accelerating development of a worldwide health and wellness product matrix spanning skin health, hair management and fat reduction, ushering in a new chapter for home-use professional-grade bioactive solutions.
About ImmVira
ImmVira is a global leading clinical-stage biotechnology company that is powered by proprietary biological engineering technology, and is dedicated to the discovery, development, manufacture and commercialization of novel oncolytic immunotherapies and engineered exosome therapies. We have strategically designed and built a risk-balanced product portfolio that comprised both potentially best-in-class oncolytic immunotherapy candidates for solid tumors and innovative engineered exosome assets for clinical application or direct commercialization. Driven by our strategic priority to become a global leader in the full spectrum of bladder cancer treatment development, we have adopted a rationalized, adaptive approach to advance oncolytic immunotherapy candidates with high clinical potential globally. In parallel, leveraging our deep expertise in biological engineering, we have pioneered development of engineered exosome candidates targeting chronic, hard-to-treat diseases as well as age-related conditions. These selected engineered exosome assets are being deliberately accelerated through strategic, differentiated regulatory pathways to enable expedited commercialization and generate sustainable cash flows that will fuel our broader drug development efforts.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
World's First Engineered Exosome for Hair Growth & Localized Fat Reduction Secure INCI Designation: ImmVira Accelerates Access to Billion-Dollar Aging-related Market
|
New global report reveals how security technology is driving business efficiency, ROI, and data-driven decision-making for business leaders.
HAMILTON, New Zealand, Jan. 15, 2026 /PRNewswire/ -- Security technology is no longer just about protection. According to Gallagher Security's newly released 2026 Security Industry Trends Report, systems once designed primarily to manage risk are now quietly enabling smarter operations, better workplace experiences, and stronger business outcomes.
Drawing on global insights, the report shows how organizations are unlocking value, return on investment, and actionable intelligence from security infrastructure already in place.
Security as invisible infrastructure
From office doors to behind-the-scenes data, security technology has become a powerful force shaping how modern organizations operate.
The report reveals that security systems are being used to do more than keep people and property safe. As organizations look to work more effectively, these systems are helping leaders understand how people interact with spaces, where time and resources are gained or lost, and how everyday decisions affect performance - often without employees noticing.
"What's striking is how invisible this shift has been," says Mark Junge, Chief Executive of Gallagher Security. "Security sits quietly in the background of daily work life, yet it's increasingly helping organizations reduce friction and make better-informed decisions."
From operational necessity to business insight
The report highlights a growing realization that security has become a valuable source of business insight. By integrating security systems with other tools and analyzing the data, organizations are improving workflows, strengthening compliance, and supporting more flexible ways of working.
A key signal of this shift is an increased focus on return on investment. Rather than viewing security purely as a cost, organizations are assessing how these systems contribute to measurable outcomes, including time saved, smoother operations, and progress toward sustainability goals.
Security moves into the boardroom
As the role of security expands, so too does who is involved in security decisions. Once managed largely within specialist teams, security is now part of broader discussions involving IT, finance, facilities, and executive leadership, reflecting how deeply these systems are embedded in modern operations.
"The conversation has moved beyond preventing problems," Junge adds. "Security is now about enabling businesses by providing the data, confidence, and flexibility needed to adapt and perform."
The Gallagher Security Industry Trends Report 2026 is now available, offering a behind-the-scenes look at how security technology is shaping modern business.
About Gallagher Security:
A global leader in integrated security solutions that unlock customer value through the power of our people and products. From making sure people go home safely to their families each night, to helping organizations become more efficient, productive, and profitable. Trusted within the highest levels of national and local government, military, commercial, industrial, healthcare, transportation, academic organizations, and small businesses in 140 countries. Visit security.gallagher.com for more information.
New global report reveals how security technology is driving business efficiency, ROI, and data-driven decision-making for business leaders.
HAMILTON, New Zealand, Jan. 15, 2026 /PRNewswire/ -- Security technology is no longer just about protection. According to Gallagher Security's newly released 2026 Security Industry Trends Report, systems once designed primarily to manage risk are now quietly enabling smarter operations, better workplace experiences, and stronger business outcomes.
Drawing on global insights, the report shows how organizations are unlocking value, return on investment, and actionable intelligence from security infrastructure already in place.
Security as invisible infrastructure
From office doors to behind-the-scenes data, security technology has become a powerful force shaping how modern organizations operate.
The report reveals that security systems are being used to do more than keep people and property safe. As organizations look to work more effectively, these systems are helping leaders understand how people interact with spaces, where time and resources are gained or lost, and how everyday decisions affect performance - often without employees noticing.
"What's striking is how invisible this shift has been," says Mark Junge, Chief Executive of Gallagher Security. "Security sits quietly in the background of daily work life, yet it's increasingly helping organizations reduce friction and make better-informed decisions."
From operational necessity to business insight
The report highlights a growing realization that security has become a valuable source of business insight. By integrating security systems with other tools and analyzing the data, organizations are improving workflows, strengthening compliance, and supporting more flexible ways of working.
A key signal of this shift is an increased focus on return on investment. Rather than viewing security purely as a cost, organizations are assessing how these systems contribute to measurable outcomes, including time saved, smoother operations, and progress toward sustainability goals.
Security moves into the boardroom
As the role of security expands, so too does who is involved in security decisions. Once managed largely within specialist teams, security is now part of broader discussions involving IT, finance, facilities, and executive leadership, reflecting how deeply these systems are embedded in modern operations.
"The conversation has moved beyond preventing problems," Junge adds. "Security is now about enabling businesses by providing the data, confidence, and flexibility needed to adapt and perform."
The Gallagher Security Industry Trends Report 2026 is now available, offering a behind-the-scenes look at how security technology is shaping modern business.
About Gallagher Security:
A global leader in integrated security solutions that unlock customer value through the power of our people and products. From making sure people go home safely to their families each night, to helping organizations become more efficient, productive, and profitable. Trusted within the highest levels of national and local government, military, commercial, industrial, healthcare, transportation, academic organizations, and small businesses in 140 countries. Visit security.gallagher.com for more information.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Security is quietly reshaping modern business, says Gallagher Security's 2026 Industry Trends Report
Security is quietly reshaping modern business, says Gallagher Security's 2026 Industry Trends Report
